ヒトミルクバンク（母乳バンク）市場- 世界の産業規模、シェア、動向、機会、予測、所有別、エンドユーザー別、地域別、競合別、2019年～2029年

世界のヒトミルクバンク（母乳バンク）市場は、2023年に3億7,084万米ドルと評価され、2029年までのCAGRは7.08%で、予測期間中に目覚ましい成長を予測しています。

世界の人乳バンク市場は、ヒト母乳の収集、保管、処理、流通に焦点を当てたヘルスケア部門を指します。ヒトミルクバンク（母乳バンク）は、未熟児、病気、または母親から直接母乳を与えることができない他の病状を持つ乳児にドナー母乳を提供する上で重要な役割を果たしています。ドナーから集められた母乳は、厳格なスクリーニング、低温殺菌、検査工程を経て、安全性と品質を保証された上で、必要とする乳児に提供されます。ヒトミルクバンク（母乳バンク）は、早産児がヒト母乳の栄養学的および免疫学的特性から大きな恩恵を受けることができる新生児集中治療室（NICU）において特に不可欠です。

主な市場促進要因

未熟児出産と医学的状態の有病率の増加

母乳育児の利点に対する意識の高まり

支援イニシアティブと政策

ミルク加工技術の進歩

主な市場課題

需要と供給の不一致

ドナーの確保と維持

主な市場動向

ドナー母乳の需要増加

母乳ドナーの参加増加

セグメント別洞察

所有別洞察

エンドユーザー別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 ヒトミルクバンク（母乳バンク）の世界市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 所有者別（病院ベース、非営利団体、政府、民間団体、その他）
  • エンドユーザー別（未熟児、胃腸障害児、代謝障害児、その他）
  • 地域別
  • 企業別（2023年）
• 市場マップ

第6章 北米のヒトミルクバンク（母乳バンク）市場の展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 所有者別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のヒトミルクバンク（母乳バンク）市場の展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 所有者別
  • エンドユーザー別
  • 国別
• 欧州国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋のヒトミルクバンク（母乳バンク）市場の展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 所有者別
  • エンドユーザー別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のヒトミルクバンク（母乳バンク）市場の展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 所有者別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのヒトミルクバンク（母乳バンク）市場の展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 所有者別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併買収（もしあれば）
• 製品上市（もしあれば）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 企業プロファイル

• Prolacta Bioscience, Inc.
  • 事業概要
  • 会社概要
  • 製品サービス
  • 財務情報
  • 最近の動向
  • キーパーソンの詳細
  • SWOT分析
• Milk Matters Milk Bank (Mowbray Maternity Hospital)
• KK Human Milk Bank
• Perron Rotary Express Milk Bank (PREM Bank)
• Royal Prince Alfred (RPA) Hospital
• Mothers Milk Bank Pty Ltd
• Mercy Health Breastmilk Bank
• Royal Brisbane and Women's Hospital (RBWH) Milk bank
• Yashoda Human Milk Bank
• Amravati by Rotary Club Of Amravati Midtown

第15章 戦略的提言

第16章 免責事項

Global Human Milk Bank Market was valued at USD 370.84 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.08% through 2029. The Global Human Milk Bank Market refers to the healthcare sector focused on the collection, storage, processing, and distribution of human breast milk. Human milk banks play a crucial role in providing donor breast milk to infants who are premature, ill, or have other medical conditions that prevent them from breastfeeding directly from their mothers. The milk collected from donors undergoes strict screening, pasteurization, and testing processes to ensure its safety and quality before being provided to infants in need. Human milk banks are particularly essential in neonatal intensive care units (NICUs) where preterm infants can benefit significantly from the nutritional and immunological properties of human breast milk.

Key Market Drivers

Increasing Prevalence of Premature Births and Medical Conditions

The increasing prevalence of premature births and medical conditions among infants has underscored the critical need for alternative feeding options, particularly for those who cannot receive breast milk directly from their mothers. Premature infants, in particular, face unique challenges due to their underdeveloped physiological systems and heightened vulnerability to infections and other complications. In this context, donor breast milk provided by human milk banks has emerged as a vital resource in the care and nourishment of these vulnerable infants. Breast milk is renowned for its unparalleled nutritional composition, containing essential nutrients, enzymes, hormones, and antibodies that support optimal growth and development. For premature infants, who often struggle with feeding and digesting formula milk, breast milk offers a gentle and easily digestible source of nourishment. Breast milk provides critical immunological protection, bolstering the infant's fragile immune system and helping to ward off infections and illnesses commonly encountered in the neonatal period.

The immunological properties of breast milk, including antibodies, cytokines, and growth factors, play a crucial role in reducing the risk of complications associated with prematurity, such as necrotizing enterocolitis (NEC), sepsis, and respiratory infections. These protective factors help to strengthen the infant's gastrointestinal tract, enhance immune function, and promote overall resilience to disease. Research has consistently shown that premature infants fed with breast milk, whether from their own mothers or from donor banks, experience lower rates of morbidity and mortality compared to those fed with formula milk.

Growing Awareness of the Benefits of Breastfeeding

The heightened awareness among healthcare professionals and the broader public concerning the myriad benefits of breastfeeding for infant health and development marks a significant shift in contemporary healthcare paradigms. This growing recognition underscores the crucial importance of ensuring access to breast milk, particularly for vulnerable infants who are unable to receive it directly from their mothers due to various medical or logistical reasons.

Healthcare professionals play a pivotal role in disseminating accurate information and evidence-based practices regarding breastfeeding to expectant parents and new mothers. Through prenatal education, antenatal classes, and postnatal support, healthcare providers impart knowledge about the nutritional, immunological, and psychological advantages of breastfeeding. They emphasize the unique composition of breast milk, which provides the ideal blend of nutrients, antibodies, and bioactive components tailored to meet the evolving needs of infants.

Supportive Initiatives and Policies

The global movement to promote breastfeeding and the establishment of human milk banks has gained significant momentum, with many countries and organizations spearheading supportive initiatives and policies to ensure access to breast milk for vulnerable infants. Recognizing the numerous health benefits of breastfeeding and the crucial role of human milk banks in providing donor breast milk, government agencies, healthcare institutions, and non-profit organizations worldwide are joining forces to develop comprehensive strategies and programs.

Government agencies play a central role in driving policy initiatives and providing regulatory frameworks to support the establishment and operation of human milk banks. Many countries have enacted legislation or issued guidelines that govern the collection, processing, and distribution of donor breast milk, ensuring safety, quality, and ethical standards are upheld. These regulations often include standards for donor screening, milk pasteurization, storage, and transportation to safeguard the health and well-being of recipients.

Technological Advancements in Milk Processing

Technological advancements have revolutionized the operations of human milk banks, enhancing the safety, efficiency, and scalability of milk processing methods. These innovations have ushered in a new era of milk banking, characterized by improved quality control, streamlined processes, and increased accessibility of donor breast milk for infants in need.

One of the most significant advancements in milk processing is in pasteurization techniques. Traditional methods of pasteurization involved heating milk to high temperatures to eliminate pathogens while preserving its nutritional properties. However, advancements in pasteurization technology, such as high-temperature short-time (HTST) pasteurization and holder pasteurization, have allowed for more precise control of heating parameters, ensuring the destruction of harmful bacteria while minimizing damage to beneficial components of breast milk. These techniques have resulted in safer and higher-quality donor milk with improved retention of bioactive factors.

Key Market Challenges

Supply and Demand Discrepancies

One of the primary challenges facing the Global Human Milk Bank Market is the imbalance between supply and demand. The demand for donor breast milk, particularly in neonatal intensive care units (NICUs) and other healthcare settings, often exceeds the available supply. This discrepancy can lead to shortages of donor milk, limiting access for vulnerable infants who rely on it for optimal nutrition and immune protection. Factors contributing to supply shortages include inadequate donor recruitment, strict donor screening criteria, and logistical challenges in milk collection, processing, and distribution. Addressing these disparities requires concerted efforts to expand donor recruitment efforts, streamline milk banking operations, and enhance collaboration among stakeholders to ensure equitable access to donor breast milk for all infants in need.

Donor Recruitment and Retention

Another significant challenge in the Global Human Milk Bank Market is the recruitment and retention of milk donors. While many women express interest in donating breast milk, various barriers may hinder their participation, including misconceptions about milk donation, concerns about time commitment and inconvenience, and logistical challenges in milk collection and transportation. Strict donor eligibility criteria, such as medical exclusions and lifestyle restrictions, may further limit the pool of potential donors. To address these challenges, milk banks must implement targeted outreach and education campaigns to raise awareness about milk donation, alleviate concerns, and highlight the importance of donor participation in supporting infant health. Offering convenient donation options, such as home-based collection services and mobile donation centers, can help overcome logistical barriers and enhance donor recruitment and retention efforts.

Key Market Trends

Rising Demand for Donor Breast Milk

The escalating demand for donor breast milk is particularly pronounced within healthcare facilities, notably neonatal intensive care units (NICUs), where preterm infants and medically fragile newborns necessitate specialized nutritional support. Within these critical care settings, infants often face a myriad of health challenges due to their premature birth or medical conditions, making the provision of optimal nutrition paramount for their survival and well-being. Donor breast milk emerges as a lifeline for these vulnerable infants, offering a unique blend of nutrients, antibodies, and bioactive factors that are crucial for their growth, development, and immune function.

Premature infants, in particular, require tailored nutritional support to address their unique needs and vulnerabilities. Breast milk, whether from their own mothers or from carefully screened donors, provides essential nutrients, growth factors, and immune-boosting properties that are vital for their growth and development. The bioactive components present in breast milk help to protect against infections, reduce the risk of necrotizing enterocolitis (NEC), and support the maturation of the infant's gastrointestinal tract and immune system.

Increasing Participation of Milk Donors

As awareness surrounding the significance of human milk banks continues to burgeon, an increasing number of women are stepping forward to volunteer as milk donors, driven by a shared commitment to support infant health and well-being. This growing recognition of the vital role played by human milk banks in providing essential nourishment to vulnerable infants has spurred a wave of altruism among breastfeeding mothers, motivating them to contribute to this critical healthcare service.

Milk banks play a pivotal role in facilitating the donation process, ensuring that donated breast milk meets stringent safety and quality standards before being distributed to infants in need. To uphold these standards, milk banks implement thorough screening processes for prospective donors, encompassing comprehensive medical histories, lifestyle assessments, and health screenings. These rigorous protocols aim to identify potential risk factors and ensure that donated breast milk is free from contaminants, pathogens, and other harmful substances.

Segmental Insights

Ownership Insights

Based on the ownership, hospital-based milk banks emerge as the dominant players, spearheading efforts to collect, process, and distribute donor breast milk to infants in need. These milk banks are typically affiliated with healthcare institutions, particularly neonatal intensive care units (NICUs) and maternity hospitals, where they play a pivotal role in providing specialized nutritional support to premature infants and medically fragile new-borns. Hospital-based milk banks benefit from direct access to donor mothers within their healthcare facilities, facilitating the collection of breast milk from lactating mothers who are delivering babies or receiving medical care.

Hospital-based milk banks leverage existing infrastructure, expertise, and resources within healthcare institutions to streamline milk banking operations and ensure adherence to rigorous quality and safety standards. They often collaborate closely with healthcare providers, including neonatologists, lactation consultants, and nurses, to integrate milk banking services into comprehensive neonatal care programs. This multidisciplinary approach enables hospital-based milk banks to provide holistic support to donor mothers, recipients, and healthcare professionals, fostering a collaborative ecosystem focused on promoting infant health and well-being.

End User Insights

Based on the end user segment, premature babies stand out as the primary beneficiaries and therefore dominant recipients within the Global Human Milk Bank Market. The prevalence of premature births continues to be a significant global health concern, with millions of infants born preterm each year. These infants, born before completing 37 weeks of gestation, often face numerous health challenges due to their underdeveloped organ systems and physiological immaturity. As a result, they frequently require specialized medical care, including nutritional support tailored to their unique needs. Donor breast milk plays a crucial role in meeting the nutritional and developmental requirements of premature infants, offering a myriad of benefits that are essential for their growth and well-being. The composition of breast milk, specifically designed by nature to meet the nutritional needs of infants, is ideally suited to support the delicate digestive systems and immature immune systems of preterm babies. Breast milk provides essential nutrients, growth factors, hormones, and antibodies that help promote optimal growth, development, and immune function in premature infants.

Regional Insights

The North American region emerges as a dominant force in the global human milk bank market, owing to several key factors that contribute to its prominence in this vital healthcare sector. North America boasts a robust healthcare infrastructure, advanced medical facilities, and a well-established network of human milk banks, which collectively support the efficient collection, processing, and distribution of donor breast milk to infants in need.

One of the primary drivers of North America's dominance in the human milk bank market is its strong commitment to promoting breastfeeding and supporting infant health. The region has witnessed widespread recognition of the benefits of breastfeeding for infant nutrition, immune protection, and overall health outcomes. As a result, there has been a concerted effort to establish and expand human milk banking programs across the continent, with a particular focus on ensuring access to donor breast milk for vulnerable populations, including premature infants and medically fragile newborns.

North America benefits from a favorable regulatory environment that facilitates the operation of human milk banks and ensures adherence to rigorous safety and quality standards. Regulatory agencies and professional organizations provide guidelines and accreditation standards for milk banking practices, ensuring that donor breast milk meets the highest standards of safety and efficacy. This regulatory framework instills confidence in healthcare providers, donor mothers, and recipient families regarding the safety and reliability of donor breast milk, thereby fostering trust and increasing utilization rates.

Key Market Players

Prolacta Bioscience, Inc.

Milk Matters Milk Bank (Mowbray Maternity Hospital)

KK Human Milk Bank

Perron Rotary Express Milk Bank (PREM Bank)

Royal Prince Alfred (RPA) Hospital

Mothers Milk Bank Pty Ltd

Mercy Health Breastmilk Bank

Royal Brisbane and Women's Hospital (RBWH) Milk bank

Yashoda Human Milk Bank

Amravati by Rotary Club Of Amravati Midtown

Report Scope:

In this report, the Global Human Milk Bank Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Human Milk Bank Market,By Ownership:

• Hospital-Based
• Non-Profit Organizations
• Government
• Private Organizations
• Others

Human Milk Bank Market,By End User:

• Premature Babies
• Infants with Gastrointestinal Disorders
• Infants with Metabolic Disorders
• Others

Human Milk Bank Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Human Milk Bank Market.

Available Customizations:

Global Human Milk Bank market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validations
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Human Milk Bank Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Ownership (Hospital-Based, Non-Profit Organizations, Government, Private Organizations, Others)
  • 5.2.2.By End User (Premature Babies, Infants with Gastrointestinal Disorders, Infants with Metabolic Disorders, Others)
  • 5.2.3.By Region
  • 5.2.4.By Company (2023)
• 5.3.Market Map

6.North America Human Milk Bank Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.ByOwnership
  • 6.2.2.ByEnd User
  • 6.2.3.By Country
• 6.3.North America: Country Analysis
  • 6.3.1.United States Human Milk Bank Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Ownership
      • 6.3.1.2.2.By End User
  • 6.3.2.Canada Human Milk Bank Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Ownership
      • 6.3.2.2.2.By End User
  • 6.3.3.Mexico Human Milk Bank Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Ownership
      • 6.3.3.2.2.By End User

7.Europe Human Milk Bank Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Ownership
  • 7.2.2.By End User
  • 7.2.3.By Country
• 7.3.Europe: Country Analysis
  • 7.3.1.Germany Human Milk Bank Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Ownership
      • 7.3.1.2.2.By End User
  • 7.3.2.United Kingdom Human Milk Bank Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Ownership
      • 7.3.2.2.2.By End User
  • 7.3.3.Italy Human Milk Bank Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecasty
      • 7.3.3.2.1.By Ownership
      • 7.3.3.2.2.By End User
  • 7.3.4.France Human Milk Bank Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Ownership
      • 7.3.4.2.2.By End User
  • 7.3.5.Spain Human Milk Bank Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Ownership
      • 7.3.5.2.2.By End User

8.Asia-Pacific Human Milk Bank Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Ownership
  • 8.2.2.By End User
  • 8.2.3.By Country
• 8.3.Asia-Pacific: Country Analysis
  • 8.3.1.China Human Milk Bank Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Ownership
      • 8.3.1.2.2.By End User
  • 8.3.2.India Human Milk Bank Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Ownership
      • 8.3.2.2.2.By End User
  • 8.3.3.Japan Human Milk Bank Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Ownership
      • 8.3.3.2.2.By End User
  • 8.3.4.South Korea Human Milk Bank Market Outlook
    • 8.3.4.1.Market Size Forecast
      • 8.3.4.1.1.By Value
    • 8.3.4.2.Market Share Forecast
      • 8.3.4.2.1.By Ownership
      • 8.3.4.2.2.By End User
  • 8.3.5.Australia Human Milk Bank Market Outlook
    • 8.3.5.1.Market Size Forecast
      • 8.3.5.1.1.By Value
    • 8.3.5.2.Market Share Forecast
      • 8.3.5.2.1.By Ownership
      • 8.3.5.2.2.By End User

9.South America Human Milk Bank Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Ownership
  • 9.2.2.By End User
  • 9.2.3.By Country
• 9.3.South America: Country Analysis
  • 9.3.1.Brazil Human Milk Bank Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Ownership
      • 9.3.1.2.2.By End User
  • 9.3.2.Argentina Human Milk Bank Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Ownership
      • 9.3.2.2.2.By End User
  • 9.3.3.Colombia Human Milk Bank Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Ownership
      • 9.3.3.2.2.By End User

10.Middle East and Africa Human Milk Bank Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value
• 10.2.Market Share Forecast
  • 10.2.1.By Ownership
  • 10.2.2.By End User
  • 10.2.3.By Country
• 10.3.MEA: Country Analysis
  • 10.3.1.South Africa Human Milk Bank Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Ownership
      • 10.3.1.2.2.By End User
  • 10.3.2.Saudi Arabia Human Milk Bank Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Ownership
      • 10.3.2.2.2.By End User
  • 10.3.3.UAE Human Milk Bank Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Ownership
      • 10.3.3.2.2.By End User

11.Market Dynamics

• 11.1.Drivers
• 11.2.Challenges

12.Market Trends Developments

• 12.1.Merger Acquisition (If Any)
• 12.2.Product Launches (If Any)
• 12.3.Recent Developments

13.Porter's Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Products

14.Company Profile

• 14.1.Prolacta Bioscience, Inc.
  • 14.1.1.Business Overview
  • 14.1.2.Company Snapshot
  • 14.1.3.Products Services
  • 14.1.4.Financials (As Reported)
  • 14.1.5.Recent Developments
  • 14.1.6.Key Personnel Details
  • 14.1.7.SWOT Analysis
• 14.2.Milk Matters Milk Bank (Mowbray Maternity Hospital)
• 14.3.KK Human Milk Bank
• 14.4.Perron Rotary Express Milk Bank (PREM Bank)
• 14.5.Royal Prince Alfred (RPA) Hospital
• 14.6.Mothers Milk Bank Pty Ltd
• 14.7.Mercy Health Breastmilk Bank
• 14.8.Royal Brisbane and Women's Hospital (RBWH) Milk bank
• 14.9.Yashoda Human Milk Bank
• 14.10.Amravati by Rotary Club Of Amravati Midtown

15.Strategic Recommendations

16.About Us Disclaimer